(48 days)
No
The 510(k) summary describes a change in coating material for existing needles and sets. There is no mention of AI or ML technology in the intended use, device description, or performance studies sections.
Yes.
The device is described as "Pajunk's PlexoLong and StimuLong sets consist of a Pajunk unipolar needle, an open ended conduction catheter and a catheter adapter, as well as a filter" and is intended for use by "professional anesthetists" for "peripheral nerve bundles," indicating its use in medical procedures to achieve a therapeutic effect (anesthesia).
No
The device description indicates that it consists of needles and catheters primarily for anesthesia and nerve stimulation, not for diagnosis.
No
The device description clearly outlines physical components like needles, catheters, adapters, and filters, indicating it is a hardware-based medical device. The submission focuses on a change in coating material for the needles, which is a hardware modification.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The description focuses on the use of needles and catheters for anesthesia and nerve stimulation, specifically targeting peripheral nerve bundles. This is a direct medical intervention on the patient's body.
- Device Description: The device components (needles, catheters, adapters, filter) are all designed for direct interaction with the patient's tissues and nervous system.
- Anatomical Site: The specified anatomical site is "peripheral nerve bundles," which are internal structures within the body.
- Intended User/Care Setting: The intended user is "professional anesthetists," indicating a clinical setting for performing medical procedures.
IVD devices are designed to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device does not fit that description. It is a medical device used for a therapeutic or diagnostic procedure performed directly on the patient.
No.
Explanation: The provided document does not contain any information or explicit mention of the device being authorized under a Predetermined Change Control Plan (PCCP). PCCP authorization would typically be explicitly stated if applicable, as it's a specific regulatory pathway for managing certain post-market changes.
Intended Use / Indications for Use
Pajunk's electrically insulated anesthesia conduction needles -- UniPlex-NanoLine cannula -are intended for professional anesthetists to facilitate the localization of peripheral nerve bundles for transient delivery of anesthetics during regional anesthesia.
Pajunk's electrically insulated anesthesia conduction needles are also provided within PlexoLong- and StimuLong and online sets intended for professional anesthetists to facilitate the transient delivery of anesthetics during regional anesthesia.
The localization of the peripheral nerve bundle is facilitated via insulated needles and impulses from a neuro-stimulator. The electric current flows from the de-insulated needles and mights innervated by the stimulated nerve bundle will the de-insulated needle the suitable setting.
Following nerve bundle localization, a catheter may be placed through the insulated anesthesia conduction needle close to the news for longer pain relief. After the needle has been withdrawn, the anesthesia conduction to to to to for to for the fielde nate that been withdra
anesther into the negipt call relater allows for bolus injections of local anesthetics into the peripheral nervous space.
The change of coating material from lacqueur to Parylene does not affect the Indications for use of the predicated devices marketed under
K042979 (Pajunk Plexolong Sets)
K033018 (Pajunk Stimulong Plus Catheter Sets)
K023218 (Pajunk Plexolong Sets)
K013041 (Pajunk Plexolong Anesthesia Sets)
K999722 (Unipolar Needles with Standard and Sprotte-tip)
The change in coating has no effect on the Indications for use of these devices already cleared for market.
Product codes (comma separated list FDA assigned to the subject device)
CAZ, BSP
Device Description
Pajunk's PlexoLong and StimuLong sets consist of a Pajunk unipolar needle, an open ended conduction catheter and a catheter adapter, as well as a filter. The coating of the needle will be chnaged to NanoLine.
Pajunk's Unipolar needles marketed separately as single shot needles under the trade name UniPlex have a lacquer coating, which will be changed to NanoLine coating,
Only the coating material of the needles is affected by this change.
The anesthesia conduction catheters and the packaging materials are the same as those used for Pajunk's PlexoLong sets cleared for market by FDA under 510(k) numbers K013041, K023218 and K042979.
The NanoLine coating is equivalent to HDC's Insul-Cote PTM needles and CLA kit (nerve stimulation) marketed under K994059. (In fact NanoLine is a better material because of a higher grade of purity. For a precise discussion of this topic see section 15 "Biocompatibility" of this submission of a special 510(k)).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peripheral nerve bundles
Indicated Patient Age Range
Not Found
Intended User / Care Setting
professional anesthetists
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing of Pajunk's anesthesia conduction needles & sets – UniPlex-NanoLine cannula, PlexoLong- & StimuLong -NanoLine sets -- has been accomplished with best results.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K000722, K023218, K033018, K013041, K023218, K042979, K994059
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5140 Anesthesia conduction kit.
(a)
Identification. An anesthesia conduction kit is a device used to administer to a patient conduction, regional, or local anesthesia. The device may contain syringes, needles, and drugs.(b)
Classification. Class II (performance standards).
0
K 053283
JAN 1 2 2006
NanoLine - Premarket Notification Submission
Image /page/0/Picture/3 description: The image shows the logo for PAJUNK Medizintechnologie. The word "PAJUNK" is in large, bold, white letters. Below that, the word "MEDIZINTECHNOLOGIE" is in smaller, black letters. The background of the logo is black and white.
510(k) Premarket Notification Submission: Summary of Safety and Effectiveness
Date of Preparation: October 27, 2005
Submitter Information/ production site:
Pajunk GmbH Karl-Hall-Straße 01 78187 Geisingen Germany Fon: +49(0)7704-9291-0 Fax: +49(0)7704-9291-610
Contact:
Christian Quaß, Regulatory Affairs Fon: +49(0)7704-9291-533 Fax: +49(0)7704-9291-605 E-Mail: christian.quass@pajunk.com
Device Information:
| Trade Names: | UniPlex NanoLine cannula,
PlexoLong-NanoLine set,
StimuLong-NanoLine set | | | |
|---------------------------|-------------------------------------------------------------------------------------------------------------------|--|--|--|
| Common Name: | Anesthesia conduction kit/ cannula | | | |
| Classification Name: | Anesthesia conduction kit | | | |
| Classification Reference: | 21 CFR 868.5140, April 1. 2003 | | | |
| Proposed Classification: | Regulatory Class: II | | | |
| Proposed Product Code: | CAZ | | | |
| Predicate Devices: | 1. K000722: Pajunk's Unipolar needles (UniPlex facet & Sprotte tip) | | | |
| | 2. K023218: Pajunk's Unipolar needles (UniPlex Tuohy tip) | | | |
| | 3. K033018: Pajunk's StimuLong set | | | |
| | 4. K013041, K023218 and K042979: Pajunk's PlexoLong set | | | |
| | 5. K994059: HDC's Insul-Cote PTM needles and CLA kit
(nerve stimulation), includes HDC's Neuro-Trace insulated | | | |
needle.
ﯿﻨﭧ
1
Image /page/1/Picture/1 description: The image shows the logo for PAJUNK MEDIZINTECHNOLOGIE. The word "PAJUNK" is in large, bold, white letters against a black background. Below that, the word "MEDIZINTECHNOLOGIE" is in smaller, thinner letters.
Device Description:
Pajunk's PlexoLong and StimuLong sets consist of a Pajunk unipolar needle, an open ended conduction catheter and a catheter adapter, as well as a filter. The coating of the needle will be chnaged to NanoLine.
Pajunk's Unipolar needles marketed separately as single shot needles under the trade name UniPlex have a lacquer coating, which will be changed to NanoLine coating,
Only the coating material of the needles is affected by this change.
The anesthesia conduction catheters and the packaging materials are the same as those used for Pajunk's PlexoLong sets cleared for market by FDA under 510(k) numbers K013041, K023218 and K042979.
The NanoLine coating is equivalent to HDC's Insul-Cote PTM needles and CLA kit (nerve stimulation) marketed under K994059. (In fact NanoLine is a better material because of a higher grade of purity. For a precise discussion of this topic see section 15 "Biocompatibility" of this submission of a special 510(k)).
The contract sterilizer other than a company name change (was IBA Griffith Micro Science, and now is Sterigenics) and the stepally hame change (was film inford Sterice, and
este sets.
Intended Use:
Pajunk's electrically insulated anesthesia conduction needles -- UniPlex-NanoLine cannula -are intended for professional anesthetists to facilitate the localization of peripheral nerve bundles for transient delivery of anesthetics during regional anesthesia.
Pajunk's electrically insulated anesthesia conduction needles are also provided within PlexoLong- and StimuLong and online sets intended for professional anesthetists to facilitate the transient delivery of anesthetics during regional anesthesia.
The localization of the peripheral nerve bundle is facilitated via insulated needles and impulses from a neuro-stimulator. The electric current flows from the de-insulated needles and mights innervated by the stimulated nerve bundle will the de-insulated needle the suitable setting.
Following nerve bundle localization, a catheter may be placed through the insulated anesthesia conduction needle close to the news for longer pain relief. After the needle has been withdrawn, the anesthesia conduction to to to to for to for the fielde nate that been withdra
anesther into the negipt call relater allows for bolus injections of local anesthetics into the peripheral nervous space.
Technology Characteristics:
Pajunk's anesthesia conduction needles & sets – UniPlex-NanoLine cannula, PlexoLong- & StimuLong -NanoLine sets – have the same technological characteristics as the predicate devices identified above.
Pajunk's anesthesia conduction needles & sets – UniPlex-NanoLine cannula, PlexoLong-NanoLine set & StimuLong-NanoLine set – are equivalent (in fact they are the same) in design, physical dimensions, luer hub, stilett, metal and plastics materials of needles and catheter, filter and connect of there, there, materials of needles and
catheter, filter and connector, as well as packaging to Pajunk's PlexoLong sets cleared for
· ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2
Image /page/2/Picture/1 description: The image shows the word "PAJUNK" in large, bold, white letters against a black background. The letters are slightly distorted, with some pixelation and jagged edges, giving the image a somewhat rough or textured appearance. The overall impression is that of a logo or brand name, possibly for a product or company.
MEDIZINTECHNOLOGIE
market by FDA under 510(k) numbers K013041, K023218 and K042979. The NanoLine coating material is substantial equivalent to HDC's Insul-Cote PTM needles and CLA hit (nerve stimulation) marketed under K994059.
Biocompatibility testing of Pajunk's anesthesia conduction needles & sets – UniPlex-NanoLine cannula, PlexoLong- & StimuLong -NanoLine sets -- has been accomplished with best results.
Summary of Design Control Activities
Changes that could affect performance of the cannula or result in a risk to the patient or the user were validated using the same protocols used to validate cleared devices. Results can be found in the summary of Risk-Analysis and in the Validation Reports of Section 09.
Conclusion:
The electrically insulating coating on the cannula is only a change in material for Pajunk GmbH products. The comparison between the predicate devices and the proposed devices demonstrates that the proposed devices are safe and effective when used according to the instructions for use supplied with the devices, as well as substantially equivalent to the predicate devices.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three stripes forming its wing. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 1 2 2006
Mr. Christian Quaß Manager Regulatory Affairs Pajunk GmbH Karl-Hall Strasse 1 78187 Geisingen GERMANY
Re: K053283
Trade/Device Name: Pajunk Anesthesia Conduction NanoLine Coated Needles Regulation Number: 868.5140 Regulation Name: Anesthesia Conduction Kit Regulatory Class: II Product Code: CAZ, BSP Dated: December 21, 2005 Received: December 27, 2005
Dear Mr. Quaß:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Quaß
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Ours
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Special Premarket Notification Submission
NanoLine
Image /page/5/Picture/2 description: The image shows the logo for PAJUNK Medizintechnologie. The word "PAJUNK" is in large, bold, white letters against a black background. Below "PAJUNK" is the word "MEDIZINTECHNOLOGIE" in a smaller, sans-serif font.
Section 04
Indications for use
510(k) Number: K053283
Device Name: Pajunk anesthesia conduction NanoLine coated needles
Indications for Use:
The change of coating material from lacqueur to Parylene does not affect the Indications for use of the predicated devices marketed under
K042979 (Pajunk Plexolong Sets)
K033018 (Pajunk Stimulong Plus Catheter Sets)
K023218 (Pajunk Plexolong Sets)
K013041 (Pajunk Plexolong Anesthesia Sets)
K999722 (Unipolar Needles with Standard and Sprotte-tip)
The change in coating has no effect on the Indications for use of these devices already cleared for market.
Prescription Use AND/OR (Per 21 CFR 801.109)
Over-The-Counter Use
(21 CFR 801 Subpan C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Clues
K.053283
Page 1 of 1
| PMN | |
|---|---|
| CQ | |
| 2006-01-05 | |
| P 1 of 1 |